Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open Label Study Of Maraviroc, Zidovudine And Lamivudine Twice Daily For The Treatment Of Antiretroviral Naïve HIV-Infected Patients With R5 HIV-1 In Russia

NCT01275625 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.

NCT NCT01275625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01275625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open Label Study Of Maraviroc, Zidovudine And Lamivudine Twice Daily For The Treatment Of Antiretroviral Naïve HIV-Infected Patients With R5 HIV-1 In Russia
Lead sponsor
ViiV Healthcare
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2011
Completion date
July 31, 2013
Enrollment
98 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hiv